You are using an unsupported browser

To continue, you will need to upgrade to a newer, more secure browser. Please upgrade now so you're ready for the event.

If you need assistance, please contact our Member and Product Support team.

Skip to main content

ACP COVID-19 Vaccination Policy

The ACP strives to provide a safe and healthy environment for all ACP meeting participants. All in-person attendees, presenters, volunteers, and ACP staff are required to be “up to date” as defined by the CDC, which includes the full primary series of the vaccine and an acceptable booster dose for those eligible. For U.S. residents, acceptable primary series vaccines are Pfizer, Moderna, Novavax or Johnson & Johnson; for individuals living outside of the United States, other primary series vaccines the WHO has indicated meet necessary criteria for safety and efficacy are also accepted.

All in person participants may attest to up to date vaccination status. Those not attesting must provide acceptable documentation of vaccination (the card or photo of the card provided at the vaccination site, a letter from a health care professional indicating vaccination is completed, or verification of vaccination status from the state department of health). ACP may accept other forms of proof as appropriate.

The CDC requires non-U.S. citizens to be fully vaccinated to enter the U.S. ACP staff will access and disclose vaccine documentation only as necessary for the ACP meeting or event.

ACP does not permit exceptions to this policy. Non-compliance will result in exclusion from the on-location ACP event.

Mask guidelines will follow those of the local jurisdiction at the time of the conference. At this time ACP expects to encourage all attendees to wear a mask, informed by guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Federal, state, and local health authorities.

Attestation

All registered in-person attendees must attest to the following at the time of registration (or subsequently if registering via phone or mail):

At the time of the 2023 Internal Medicine Meeting I agree to be up to date with my COVID-19 vaccination, which means I will have received a full primary series and booster dose as eligible. If at any time while traveling to or during the meeting, I develop symptoms, I will follow CDC guidelines on testing and isolation.